Community/Retail

In this clip, Mark Neuenschwander, President of The Neuenschwander Company, discussed IV preparation errors and the importance of workflow technologies in reducing error rates.

Patricia C. Kienle, BSPharm, MPA, FASHP, director of accreditation and medication safety at Cardinal Health Innovative Delivery Solutions, discusses the impact of IV drug shortages and the importance of preparing for these shortages.

Fred Massoomi, PharmD, FASHP, Senior Director at Visante, explains how USP 800 regulations will drive the use of closed system transfer devices in health care.

Drug shortages aren’t going away anytime soon, which is why it’s important for pharmacies to put preparedness plans in place ahead of future IV shortages, according to an interactive discussion held this week at the ASHP Summer Meeting and Exhibition.

Leticia Shea, PharmD, BCACP, Associate Professor of Pharmacy at Regis University, discusses why it's important for pharmacists to stay up-to-date on the latest laws and research surrounding medical marijuana use.

Joshua Evans, PhD, assistant professor of health care ethics at Regis University, discusses some of the common ethical dilemmas associated with medical marijuana.

Fred Massoomi, PharmD, FASHP, senior director for Visante, discusses using closed system transfer devices.

Officials with the FDA have approved Lannett Company’s Levofloxacin Oral Solution.

In this clip, Fred Massoomi, PharmD, FASHP, Senior Director at Visante, offers advice on the best practices for USP 800 compliance, including gap analysis, individual monitoring, and education.

The FDA has approved pegfilgrastim-jmdb (Fulphila, Mylan GmbH) as the first biosimilar to pegfilgrastim (Neulasta) to help reduce the chance of fever-causing infection for a population of patients with cancer.

A pharmacy that truly differentiates itself may create a niche that the giant online retailer would have trouble encroaching upon.

For health care providers, staying up to date on drug development trends is crucial to understanding the implications of these therapies and how they can best help their patients.

An emerging area of investigation in asthma and chronic obstructive pulmonary disease is use of statins.

Combining pegilodecakin (AM0010) with nivolumab (Opdivo) or pembrolizumab (Keytruda) induced an overall response rate (ORR) of 41% in patients with advanced non–small cell lung cancer (NSCLC), according to findings from an early phase study presented at the 2018 ASCO Annual meeting.

In this clip, Dennis Killian, PharmD, PhD, Director of Pharmacy at Peninsula Regional Medical Center, compares the use of premixed with compound IV products for enhanced patient safety.

The new section will provide an enhanced focus on ASHP’s efforts to help its members provide optimal patient care and comprehensive medication therapy management in the specialty pharmacy environment.

Pharmacists have a crucial role to play in identifying medication safety issues and implementing best practices to prevent errors, according to the ISMP.

In this clip, Dennis Killian, PharmD, PhD, Director of Pharmacy at Peninsula Regional Medical Center, discusses the features and functionalities to consider when purchasing a new infusion pump.

Leticia Shea, PharmD, BCACP, Associate Professor of Pharmacy at Regis University, discusses why it's important for pharmacists to educate patients on medical cannabis use.

Dennis Killian, PharmD, PhD, Director of Pharmacy at Peninsula Regional Medical Center, talks about the benefits of using ready-to-use, premixed IV products versus compound IV products.

Sponsored by ASHP and the ASHP Research and Education Foundation, the award honors student members in their second through fourth professional years of pharmacy school.

The FDA has approved baricitinib (Olumiant), a once-daily oral drug for adults with moderately-to-severely active rheumatoid arthritis.

An extension trial assesses the efficacy and safety of extending edaravone treatment past the FDA-approved 6 cycles.

Our team is on site in Denver all week covering from ASHP Summer 2018.

Studies explore the efficacy and safety of anticoagulation for atrial fibrillation in hemodialysis.

When individuals who are at risk for HIV use PrEP, and use it appropriately, risk of infection is significantly lowered.